Pulmonary squamous cell carcinoma and sorafenib

KEY CLINICAL MESSAGE: Pulmonary squamous cell carcinomas are not often thought to sensitive to targeted agents, like their cousin the adenocarcinoma of the lung. With appropriate testing of molecular markers, squamous cell carcinomas, like adenocarcinomas of the lung, melanomas, and renal cell carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Gollard, Russell, Garcia, Diana, Natale, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302627/
https://www.ncbi.nlm.nih.gov/pubmed/25614813
http://dx.doi.org/10.1002/ccr3.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302627/
https://www.ncbi.nlm.nih.gov/pubmed/25614813
http://dx.doi.org/10.1002/ccr3.95

Ejemplares similares